Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Timm Greulich, Anna Albert, Werner Cassel, Tobias Boeselt, Erika Peychev, Andreas Klemmer, Francini Ferreira, Christian Clarenbach, Maria L Torres-Duran, Alice M Turner & Marc Miravitlles. (2022) Opinions and Attitudes of Pulmonologists About Augmentation Therapy in Patients with Alpha-1 Antitrypsin Deficiency. A Survey of the EARCO Group. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 53-64.
Read now
Read now
James A Stockley, Robert A Stockley & Elizabeth Sapey. (2021) There is No Fast Track to Identify Fast Decliners in Alpha-1 Antitrypsin Deficiency by Spirometry: A Longitudinal Study of Repeated Measurements. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 835-840.
Read now
Read now
Farah Mobeen, Ross G. Edgar, Anita Pye, Robert A. Stockley & Alice M. Turner. (2021) Relationship between Depression and Anxiety, Health Status and Lung Function in Patients with Alpha-1 Antitrypsin Deficiency. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:6, pages 621-629.
Read now
Read now
Mark Quinn, Paul Ellis, Anita Pye & Alice M Turner. (2020) Obstacles to Early Diagnosis and Treatment of Alpha-1 Antitrypsin Deficiency: Current Perspectives. Therapeutics and Clinical Risk Management 16, pages 1243-1255.
Read now
Read now
Kylie B R Belchamber, Eloise M Walker, Robert A Stockley & Elizabeth Sapey. (2020) Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3183-3192.
Read now
Read now
Cristina Esquinas, Sonia Serreri, Miriam Barrecheguren, Esther Rodriguez, Alexa Nuñez, Francisco Casas-Maldonado, Ignacio Blanco, Pietro Pirina, Beatriz Lara & Marc Miravitlles. (2018) Long-term evolution of lung function in individuals with alpha-1 antitrypsin deficiency from the Spanish registry (REDAAT). International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1001-1007.
Read now
Read now
Kenneth R Chapman, Joanna Chorostowska-Wynimko, A Rembert Koczulla, Ilaria Ferrarotti & Noel G McElvaney. (2018) Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 419-432.
Read now
Read now
Ross G Edgar, Mitesh Patel, Susan Bayliss, Diana Crossley, Elizabeth Sapey & Alice M Turner. (2017) Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 1295-1308.
Read now
Read now
Articles from other publishers (25)
Pei Yee Tiew, Oliver W. Meldrum & Sanjay H. Chotirmall. (2023) Applying Next-Generation Sequencing and Multi-Omics in Chronic Obstructive Pulmonary Disease. International Journal of Molecular Sciences 24:3, pages 2955.
Crossref
Crossref
Robert A. STOCKLEY. (2023) Clinical aspect of AATD. Minerva Respiratory Medicine 62:1.
Crossref
Crossref
Marc Miravitlles, Alice M. Turner, María Torres-Duran, Hanan Tanash, Carlota Rodríguez-García, José Luis López-Campos, Jan Chlumsky, Catarina Guimaraes, Juan Luis Rodríguez-Hermosa, Angelo Corsico, Cristina Martinez-González, José María Hernández-Pérez, Ana Bustamante, David G. Parr, Francisco Casas-Maldonado, Ana Hecimovic, Wim Janssens, Beatriz Lara, Miriam Barrecheguren, Cruz González, Jan Stolk, Cristina Esquinas & Christian F. Clarenbach. (2022) Clinical and functional characteristics of individuals with alpha-1 antitrypsin deficiency: EARCO international registry. Respiratory Research 23:1.
Crossref
Crossref
Kuniaki Seyama, Masaru Suzuki, Sadatomo Tasaka, Toshihiro Nukiwa, Tadashi Sato, Satoshi Konno, Susan Sorrells, Junliang Chen, Maria Esperança Aragonés & Hitoshi Minamino. (2022) Long-term safety of Prolastin®-C, an alpha1-proteinase inhibitor, in Japanese patients with alpha1-antitrypsin deficiency. Respiratory Investigation 60:6, pages 831-839.
Crossref
Crossref
J.-F. Mornex, M. Balduyck, M. Bouchecareilh, A. Cuvelier, R. Epaud, M. Kerjouan, O. Le Rouzic, C. Pison, L. Plantier, M.-C. Pujazon, M. Reynaud-Gaubert, A. Toutain, B. Trumbic, M.-C. Willemin, M. Zysman, O. Brun, M. Campana, F. Chabot, V. Chamouard, M. Dechomet, J. Fauve, B. Girerd, C. Gnakamene, S. Lefrançois, J.-N. Lombard, B. Maitre, C. Maynié-François, A. Moerman, A. Payancé, P. Reix, D. Revel, M.-P. Revel, M. Schuers, P. Terrioux, D. Theron, F. Willersinn, V. Cottin & H. Mal. (2022) Atteinte pulmonaire du déficit en alpha-1 antitrypsine. Recommandations pratiques pour le diagnostic et la prise en charge. Revue des Maladies Respiratoires 39:7, pages 633-656.
Crossref
Crossref
Maria Prendecki & Katharine M. Lodge. (2022) Alpha-1 Antitrypsin Deficiency: Does Increased Neutrophil Adhesion Contribute to Lung Damage?. American Journal of Respiratory Cell and Molecular Biology 67:1, pages 6-7.
Crossref
Crossref
Robert Andrew Stockley. 2022. Encyclopedia of Respiratory Medicine. Encyclopedia of Respiratory Medicine
675
685
.
Iris G.M. Schouten, Marise J. Kasteleyn, Roula Tsonaka, Robert Bals, Alice C. Turner, Ilaria Ferrarotti, Angelo G. Corsico, Beatriz Lara, Marc Miravitlles, Robert A. Stockley & Jan Stolk. (2021)
Long-term effect of α
1
-antitrypsin augmentation therapy on the decline of FEV
1
in deficient patients: an analysis of the AIR database
. ERJ Open Research 7:3, pages 00194-2021.
Crossref
Crossref
Peter Lange, Engi Ahmed, Zakaria Mohamed Lahmar, Fernando J. Martinez & Arnaud Bourdin. (2021)
Natural history and mechanisms of
COPD
. Respirology 26:4, pages 298-321.
Crossref
Crossref
James Crapo, Abhya Gupta, David A Lynch, Jens Vogel-Claussen, Henrik Watz, Alice M Turner, Robert M Mroz, Wim Janssens, Andrea Ludwig-Sengpiel, Markus Beck, Bérengère Langellier, Carina Ittrich, Frank Risse & Claudia Diefenbach. (2021) FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD. BMJ Open 11:3, pages e042526.
Crossref
Crossref
Roxana Cortes-Lopez & Igor Barjaktarevic. (2020) Alpha-1 Antitrypsin Deficiency: a Rare Disease?. Current Allergy and Asthma Reports 20:9.
Crossref
Crossref
José Luis López-Campos, Laura Carrasco Hernandez & Candelaria Caballero Eraso. (2020) Implications of a Change of Paradigm in Alpha1 Antitrypsin Deficiency Augmentation Therapy: From Biochemical to Clinical Efficacy. Journal of Clinical Medicine 9:8, pages 2526.
Crossref
Crossref
Robert. A. Stockley. (2020) Alpha-1 Antitrypsin Deficiency: The Learning Goes On. American Journal of Respiratory and Critical Care Medicine 202:1, pages 6-7.
Crossref
Crossref
Jack Dummer, Claudia C. Dobler, Mark Holmes, Daniel Chambers, Ian A. Yang, Lianne Parkin, Sheree Smith, Peter Wark, Anouk Dev, Sandra Hodge, Eli Dabscheck, Julian Gooi, Sameh Samuel, Steven Knowles & Anne E. Holland. (2020) Diagnosis and treatment of lung disease associated with alpha one‐antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand*. Respirology 25:3, pages 321-335.
Crossref
Crossref
Diana Crossley, Robert Stockley & Elizabeth Sapey. (2019) Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?. Drugs & Aging 36:9, pages 823-840.
Crossref
Crossref
Hannah A. Blair. (2019) Human α1-proteinase inhibitor (Respreeza®) in α1-antitrypsin deficiency emphysema: a profile of its use in the EU. Drugs & Therapy Perspectives 35:8, pages 363-368.
Crossref
Crossref
Robert A. Stockley, David M. G. Halpin, Bartolome R. Celli & Dave Singh. (2019) Chronic Obstructive Pulmonary Disease Biomarkers and Their Interpretation. American Journal of Respiratory and Critical Care Medicine 199:10, pages 1195-1204.
Crossref
Crossref
Robert A. Stockley, Ross G. Edgar, Sian Starkey & Alice M. Turner. (2018) Health status decline in α-1 antitrypsin deficiency: a feasible outcome for disease modifying therapies?. Respiratory Research 19:1.
Crossref
Crossref
Article Editorial. (2018) Diagnosis and treatment of pulmonarydisease in α1-antitrypsin deficiency: a statement of European Respiratory Society. Russian Pulmonology 28:3, pages 273-295.
Crossref
Crossref
Emma V. Low, Siân M. Hughes, Safia Zaffarullah, Dimitris Kantas, Robert Andrew Stockley & Alice M. Turner. (2018) ICS Use May Modify FEV<sub>1</sub> Decline in α<sub>1</sub>-Antitrypsin Deficiency Patients with Relatively High Blood Eosinophils. Respiration 95:2, pages 114-121.
Crossref
Crossref
Marc Miravitlles, Asger Dirksen, Ilaria Ferrarotti, Vladimir Koblizek, Peter Lange, Ravi Mahadeva, Noel G. McElvaney, David Parr, Eeva Piitulainen, Nicolas Roche, Jan Stolk, Gabriel Thabut, Alice Turner, Claus Vogelmeier & Robert A. Stockley. (2017)
European Respiratory Society statement: diagnosis and treatment of pulmonary disease in α
1
-antitrypsin deficiency
. European Respiratory Journal 50:5, pages 1700610.
Crossref
Crossref
James A. Stockley, Asem M. Ismail, Siân M. Hughes, Ross Edgar, Robert A. Stockley & Elizabeth Sapey. (2017)
Maximal mid-expiratory flow detects early lung disease in α
1
-antitrypsin deficiency
. European Respiratory Journal 49:3, pages 1602055.
Crossref
Crossref
Joan B. Soriano & Ravi Mahadeva. (2017)
α
1
-Antitrypsin deficiency: count me in please!
. European Respiratory Journal 49:1, pages 1601941.
Crossref
Crossref
Robert Stockley. 2017. Alpha-1-antitrypsin Deficiency. Alpha-1-antitrypsin Deficiency
101
116
.
Kate McKeage & Katherine A. Lyseng-Williamson. (2016) Human α1-proteinase inhibitor (Respreeza®) in α1-antitrypsin deficiency emphysema: a guide to its use in the EU. Drugs & Therapy Perspectives 32:10, pages 422-427.
Crossref
Crossref